compounded tirzepatide microdose Weight Management Program — Program Microdosing

According to the FDA prescribing information, nausea, diarrhea, and vomiting are among the most common side effects, with rates varying by dose

This information can help you identify patterns and adjust your intake accordingly, and it provides valuable information to share with your healthcare team if concerns arise

Theres typically strict criteria for who can be approved for these medications for weight loss purposes

Studies have shown that users on the highest dose lost an average of 20.9% of their body weight, making it a strong consideration for those facing significant weight loss challenges

Medication options are offered when appropriate but are not requiredlifestyle-only plans are also available